Atlas Trials

Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension Study

Clinical trial NCT06177691 · UNKNOWN

Trial details

NCT number
NCT06177691
Sponsor
Jaeb Center for Health Research
Status
UNKNOWN
Study type
OBSERVATIONAL
Type1 Diabetes
Start date
2021-05-07
Primary completion
2025-12-18
Enrollment
77

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.